B
Burning Rock Biotech Limited D
D
BNR
11.550
USD
0.35
(3.13%)
مغلق
حجم التداول
1,240
الربح لكل سهم
0
العائد الربحي
-
P/E
-6
حجم السوق
124,354,184
العنوان: Burning Rock Biotech Limited
القطاع: Healthcare
الصناعة: Diagnostics & Research
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.